Diligence memo · auto-generated · as of July 2, 2026
Sanovia Corp
Sanovia Corp looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Sanovia Corp operates in Pharmaceuticals, based in PHILADELPHIA.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Sanovia Corp has raised $9.3M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $8.2M on 2009-04-22.
Most recent recorded round closed around 2010-05-12.
Valuation (modeled)modeled
Provath models Sanovia Corp at approximately $34M (range $1.3M–$185M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.19× the median modeled value of Series A Pharmaceuticals companies in 2010–2012 (57 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 13 months.
Last raise 16.1 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round was 7.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 52% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 35% of those peers.
Closest niche peers: Satori Pharmaceuticals Inc, Labrys Biologics, Inc., Telsar Pharma, Inc., Acetylon Pharmaceuticals, Inc., Seldar Pharma, Inc..
Peoplefiled
9 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.